BioTech
FDA: Don’t rush publishing your diversity guidance plan. Take your time and do it right
When Congress passed the Food and Drug Omnibus Reform Act (FDORA) in December 2022, it was hailed as a landmark step toward codifying diversity and
Tamei Elliott and Maria Vassileva
June 26, 2024